Literature DB >> 18812191

Heparin-like glycosaminoglycans prevent the infection of measles virus in SLAM-negative cell lines.

Yuri Terao-Muto1, Misako Yoneda, Takahiro Seki, Akira Watanabe, Kyoko Tsukiyama-Kohara, Kentaro Fujita, Chieko Kai.   

Abstract

The wide tissue tropism of the measles virus (MV) suggests that it involves ubiquitously expressed molecules. We have constructed a recombinant MV expressing the enhanced green fluorescent protein (EGFP) (rMV-EGFP) and demonstrated that the rMV-EGFP infected several cell types (HEK-293, HepG2, Hep3B, Huh7, and WRL68 cells) that do not express the human signalling lymphocyte activation molecule (SLAM), which is known as a cellular receptor for morbilliviruses. MV infection of HEK-293 and HepG2 cells was not inhibited in an infectivity-inhibition assay using an anti-SLAM monoclonal antibody, indicating that MV could infect cells without using SLAM. Soluble heparin (HP) inhibited the rMV-EGFP infectivity in SLAM-negative cell lines in a dose-dependent manner. Direct interaction between purified virions and HP was detected in a surface plasmon resonance assay. We also demonstrated that the hemagglutinin (H) protein, but not the fusion (F) protein is responsible for the interaction between the virions and HP. Taken together, our results suggest that HP-like glycosaminoglycans bind to the H protein of MV and play a key role in the infection of SLAM-negative cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812191     DOI: 10.1016/j.antiviral.2008.08.006

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  18 in total

1.  CD147/EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells.

Authors:  Akira Watanabe; Misako Yoneda; Fusako Ikeda; Yuri Terao-Muto; Hiroki Sato; Chieko Kai
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

2.  A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.

Authors:  Che C Colpitts; Luis M Schang
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

3.  Newly identified minor phosphorylation site threonine-279 of measles virus nucleoprotein is a prerequisite for nucleocapsid formation.

Authors:  Akihiro Sugai; Hiroki Sato; Kyoji Hagiwara; Hiroko Kozuka-Hata; Masaaki Oyama; Misako Yoneda; Chieko Kai
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

4.  Phosphorylation of measles virus nucleoprotein affects viral growth by changing gene expression and genomic RNA stability.

Authors:  Akihiro Sugai; Hiroki Sato; Misako Yoneda; Chieko Kai
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

5.  Participation of heparin binding proteins from the surface of Leishmania (Viannia) braziliensis promastigotes in the adhesion of parasites to Lutzomyia longipalpis cells (Lulo) in vitro.

Authors:  Luzia Monteiro de Castro Côrtes; Mirian Claudia de Souza Pereira; Franklin Souza da Silva; Bernardo Acácio Santini Pereira; Francisco Odêncio de Oliveira Junior; Renata Oliveira de Araújo Soares; Reginaldo Peçanha Brazil; Leny Toma; Carolina Meloni Vicente; Helena Bonciani Nader; Maria de Fátima Madeira; Felio J Bello; Carlos Roberto Alves
Journal:  Parasit Vectors       Date:  2012-07-17       Impact factor: 3.876

6.  Selective translation of the measles virus nucleocapsid mRNA by la protein.

Authors:  Yoshihisa Inoue; Hiroki Sato; Kentaro Fujita; Kyoko Tsukiyama-Kohara; Misako Yoneda; Chieko Kai
Journal:  Front Microbiol       Date:  2011-08-23       Impact factor: 5.640

7.  Cell tropism and pathogenesis of measles virus in monkeys.

Authors:  Sei-Ich Kato; Kyosuke Nagata; Kaoru Takeuchi
Journal:  Front Microbiol       Date:  2012-01-30       Impact factor: 5.640

8.  Morbillivirus receptors and tropism: multiple pathways for infection.

Authors:  Hiroki Sato; Misako Yoneda; Tomoyuki Honda; Chieko Kai
Journal:  Front Microbiol       Date:  2012-03-01       Impact factor: 5.640

9.  Heparan sulfate-dependent enhancement of henipavirus infection.

Authors:  Cyrille Mathieu; Kévin P Dhondt; Marie Châlons; Stéphane Mély; Hervé Raoul; Didier Negre; François-Loïc Cosset; Denis Gerlier; Romain R Vivès; Branka Horvat
Journal:  mBio       Date:  2015-03-10       Impact factor: 7.867

10.  Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.

Authors:  Misako Yoneda; Marie-Claude Georges-Courbot; Fusako Ikeda; Miho Ishii; Noriyo Nagata; Frederic Jacquot; Hervé Raoul; Hiroki Sato; Chieko Kai
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.